Lumos Diagnostics Signs Second ANZ Distribution Agreement for FebriDx®
9 September 2025
Lumos Diagnostics has signed a new distribution agreement with Amtech, part of the YesGroup alliance, to expand access to its flagship rapid diagnostic test, FebriDx®, across Australia and New Zealand.
YesGroup is a major Australasian medical and safety supplies alliance, that brings together two trusted brands, Yes Medical, and Amtech Medical. YesGroup employs over 150 team members and offers a portfolio with more than 25,000 product lines across multiple brands.
Doug Ward, CEO of Lumos Diagnostics said:
“We are delighted to expand FebriDx® distribution in Australia and New Zealand through this new partnership with YesGroup. With their reach and long-standing presence in the local healthcare market, alongside our existing agreement with Henry Schein, we are well positioned to make FebriDx® more widely accessible to clinicians.”
Click to read the ASX release.
YesGroup is a major Australasian medical and safety supplies alliance, that brings together two trusted brands, Yes Medical, and Amtech Medical. YesGroup employs over 150 team members and offers a portfolio with more than 25,000 product lines across multiple brands.
Doug Ward, CEO of Lumos Diagnostics said:
“We are delighted to expand FebriDx® distribution in Australia and New Zealand through this new partnership with YesGroup. With their reach and long-standing presence in the local healthcare market, alongside our existing agreement with Henry Schein, we are well positioned to make FebriDx® more widely accessible to clinicians.”
Click to read the ASX release.
